Capricor Therapeutics Inc Share Price

NASDAQ: CAPR

Small Cap

$6.22

+0.18

(+3.06%)

as on September 17, 2025 at 1:29 am IST

$₹

Capricor Therapeutics Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$6.12
Day's Price Range
$6.38
$6.22
1.61%
Downside
2.57%
Upside
52 Week's Low
52 Week's High
$4.59
52-Week Price Range
$23.4
$6.22
26.21%
Downside
276.21%
Upside

Capricor Therapeutics Inc share price movements today

Previous Close: $6.04
Open: $6.21
Volume: 971.6K
Day's Low - High: $6.12 - $6.38
52 Week Low - High: $4.59 - $23.4

Capricor Therapeutics Inc Historical Returns

1 Month Return: -21.86 %
3 Month Return: -48.97 %
1 Year Return: + 22.44 %
3 Year Return: + 2.98 %
5 Year Return: + 5.6 %

Capricor Therapeutics Inc Stock Fundamentals & Key Indicators

Check Capricor Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$284.4M

EPS (TTM)

-2.1443

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-71.8M

Revenue (TTM)

13.4M

Profit Margin

0.00%

Return On Equity TTM

6.14%

Capricor Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Capricor Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Capricor Therapeutics Inc	BUY	$284.4M	5.6%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Capricor Therapeutics Inc Stock including INR - Dollar returns

The Capricor Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Capricor Therapeutics Inc investment value today

Current value as on today

₹1,27,039

Returns

₹27,039

(+27.04%)

Returns from Capricor Therapeutics Inc Stock

₹22,441 (+22.44%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Capricor Therapeutics Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Capricor Therapeutics Inc. Average target price of $20.6

Capricor Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Capricor Therapeutics Inc.

What analysts predicted

69.81%UPSIDE

Target Price

$20.6

Current Price

$6.22

Analyzed by

10 Analysts

Target

$20.60

Capricor Therapeutics Inc target price $20.6, a slight upside of 69.81% compared to current price of $6.22. According to 10 analysts rating.

Capricor Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Capricor Therapeutics Inc Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-36% versus previous 30 day period

Capricor Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	2	3	6	12	4	3	2	11	-	-
Gross Profit	2	3	5	11	4	3	1	10	0	-
Operating Income	-8	-7	-6	-1	-10	-11	-13	-7	-24	-27
EBITDA	-7	-7	-6	0	-9	-11	-12	-7	-24	-25
Interest Expense	415	-	-	415	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-7	-6	0	-9	-11	-12	-7	-24	-25
Income Tax Expense	-416	0	0	0	0	0	-	-	-	-
Net Income	-7	-7	-6	0	-9	-11	-12	-7	-24	-25
Net Profit Margin	-260.06%	-188.08%	-103.31%	-6.30%	-199.59%	-277.01%	-555.13%	-63.94%	0.00%	0.00%

Capricor Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	3	3	1	1	1	0	0	2	25	22
Gross Profit	-9	3	1	1	1	0	0	1	24	20
Operating Income	-12	-16	-12	-15	-7	-13	-20	-29	-24	-42
EBITDA	-12	-16	-12	-15	-7	-13	-20	-29	-23	-41
Interest Expense	0	0	0	-	-	-	1	1	-	-
Depreciation	-	-	0	0	0	0	0	0	0	1
Income Before Tax	-12	-18	2	-15	-7	-13	-20	-29	-22	-40
Income Tax Expense	0	0	0	0	0	0	0	0	0	-
Net Income	-12	-18	2	-15	-7	-13	-20	-29	-22	-40
Net Profit Margin	-340.50%	-589.53%	177.84%	-908.91%	-760.40%	-4401.93%	-8176.06%	-1137.59%	-88.52%	-181.71%

Capricor Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-7	-6	0	-9	-10	-12	-7	-24	-25
Operating Cash Flow	-9	-8	-11	-1	-12	-11	-14	-6	-20
Investing Cash Flow	6	7	-5	-9	14	2	-123	23	-
Financing Cash Flow	2	0	23	2	2	67	81	0	0
Change in Cash	0	0	5	-8	4	57	-57	17	-5

Capricor Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-18	2	-15	-7	-13	-20	-29	-22	-40
Operating Cash Flow	-15	-14	-13	-6	-10	-16	4	-25	-39
Investing Cash Flow	-5	4	4	-3	5	-1	-35	5	-116
Financing Cash Flow	18	11	6	9	33	20	4	25	152
Change in Cash	-2	2	-2	0	28	2	-25	5	-3

Global Institutional Holdings in Capricor Therapeutics Inc

Funds	Holdings
BlackRock Inc	6.44%
Vanguard Group Inc	4.95%
Farallon Capital Management, L.L.C.	4.92%
State Street Corp	4.03%
Geode Capital Management, LLC	1.97%

See all

Insights on Capricor Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 2.26M → 11.13M (in $), with an average increase of 79.7% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 45.7%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 113.5%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -7.11M → -25.91M (in $), with an average decrease of 124.5% per quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, CAPR stock has moved down by -21.9%

About Capricor Therapeutics Inc

capricor therapeutics, inc. (nasdaq: capr) is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapeutics for the treatment of rare disorders. our innovative technology builds upon a large body of scientific research and enables us to approach the treatment of diseases in novel ways. capricor’s lead candidate, cap-1002, is an “off-the-shelf” cardiac cell therapy that is currently in clinical development for the treatment of duchenne muscular dystrophy (dmd). cap-1002 consists of allogeneic cardiosphere-derived cells, or cdcs, a unique population of cells which include progenitor cells that have been shown to exert potent immunomodulatory activity, which alters the immune system’s activity to stimulate cellular regeneration. cdcs have been the subject of over 100 peer-reviewed scientific publications and have been administered to approximately 140 human subjects across several clinical trials. capricor has

Organisation	Capricor Therapeutics Inc
Headquarters	10865 Road to the Cure, San Diego, CA, United States, 92121
Industry	Health Technology
CEO	Dr. Linda Marbán Ph.D.
E-voting on shares	Click here to vote

Key Management of Capricor Therapeutics Inc

Name	Title
Catherine Lee Kelleher M.D.	Consultant
Mr. Anthony J. Bergmann M.B.A.	CFO & Corporate Treasurer
Dr. Linda Marbán Ph.D.	Co-Founder, President, CEO & Director
Ms. Karen G. Krasney Esq., J.D.	Executive VP, General Counsel & Secretary
Dr. Kristi A. H. Elliott Ph.D.	Chief Operating & Science Officer
Mr. Minghao Sun Ph.D.	Senior Vice President of Quality Control, Research & Product Development
Mr. Mark Awadalla	Chief Development Officer
Dr. Micheal Binks M.D.	Chief Medical Officer
Dr. Frank Isaac Litvack FACC, M.D.	Executive Chairman of the Board

FAQs

What is Capricor Therapeutics Inc share price today?

Capricor Therapeutics Inc share price today is $6.22 as on September 17, 2025 at 1:29 am IST at the close of the market. Capricor Therapeutics Inc share today touched a day high of $6.38 and a low of $6.12.

What is the 52 week high and 52 week low for Capricor Therapeutics Inc share?

Capricor Therapeutics Inc share touched a 52 week high of $23.4 on October 15, 2024 and a 52 week low of $4.59 on September 17, 2024. Capricor Therapeutics Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $6.22,which is 73.42% down from its 52 week high and 35.51% up from its 52 week low.

What is Capricor Therapeutics Inc's market capitalisation today?

Capricor Therapeutics Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Capricor Therapeutics Inc Stock (CAPR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Capricor Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Capricor Therapeutics Inc Shares that will get you 0.2412 shares as per Capricor Therapeutics Inc share price of $6.22 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Capricor Therapeutics Inc Stock (CAPR) from India?

Indian investors can start investing in Capricor Therapeutics Inc (CAPR) shares with as little as ₹87.816 or $1 (as of September 17, 2025 at 4:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Capricor Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 4:42 pm IST). Based on Capricor Therapeutics Inc share’s latest price of $6.22 as on September 17, 2025 at 1:29 am IST, you will get 1.6077 shares of Capricor Therapeutics Inc. Learn more about fractional shares .

What are the returns that Capricor Therapeutics Inc has given to Indian investors in the last 5 years?

Capricor Therapeutics Inc stock has given 5.6% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?